Article
Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Human pathology - 1 Dec 2020
Nozaki Yui, Yamamoto Hidetaka, Iwasaki Takeshi, Sato Masanobu, Jiromaru Rina, Hongo Takahiro, Yasumatsu Ryuji, Oda Yoshinao
Abstract excerpt
NTRK1/3, ALK, and ROS1 translocations have been reported in a minor subset of papillary thyroid carcinomas (PTCs). We aimed to elucidate the prevalence and clinicopathological characteristics of these gene rearrangements and the utility of immunohistochemistry (IHC) in PTC and anaplastic thyroid carcinoma (ATC). We screened nonradiation-exposed cases of 307 PTCs and 16 ATCs by IHC for pan-Trk, ALK, and ROS1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
